Epigenomic Profiling Positions ATF7 as a Core Regulator of Colonic Inflammation
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70831 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Fang Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Activating Transcription Factors, Colon, Colitis, Inflammation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Mitochondrial dysfunction plays a central role in epithelial damage and persistent inflammation in ulcerative colitis (UC), but the transcriptional mechanisms that govern mitochondrial quality control in the intestinal epithelium remain poorly defined. Here, we identify Activating Transcription Factor 7 (ATF7) as a key regulator of mitophagy in colonic epithelial cells. Integrative transcriptomic and epigenomic analyses of patient‐derived mucosal samples revealed marked ATF7 downregulation and widespread activation of inflammatory pathways. Chromatin immunoprecipitation and luciferase reporter assays demonstrated that ATF7 directly binds to and activates the promoter of PINK1, a master regulator of mitophagy. Genetic ablation of ATF7 or PINK1 in human epithelial cells impaired mitophagy, disrupted mitochondrial membrane potential, and increased reactive oxygen species. In vivo, intestinal epithelial cell‐specific knockout of ATF7 or PINK1 exacerbated dextran sulfate sodium‐induced colitis, with greater epithelial injury, elevated cytokine production, and transcriptional activation of TNF, NF‐kappaB, and inflammatory bowel disease signalling pathways. These results establish ATF7 as a critical transcriptional regulator linking mitochondrial homeostasis to epithelial resilience in the inflamed colon.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Gastroenterology, The First Affiliated Hospital of Shihezi University, Shihezi, China.
- Department of Endoscopy and Digestive System, Guizhou Provincial People's Hospital, Guiyang, China.
ORCID-Profile: Liangru Zhu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Liu, F., Chen, Y., Li, J., Li, J., Yu, Q., Zhang, X., & Zhu, L. (2025). Epigenomic Profiling Positions ATF7 as a Core Regulator of Colonic Inflammation. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70831
Vancouver
Liu F, Chen Y, Li J, Li J, Yu Q, Zhang X, et al. Epigenomic Profiling Positions ATF7 as a Core Regulator of Colonic Inflammation. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70831
BibTeX
@article{Liu2025,
author = {Liu, Fang and Chen, Yidong and Li, Jiamin and Li, Junrong and Yu, Qi and Zhang, Xiaopeng and Zhu, Liangru},
title = {Epigenomic Profiling Positions ATF7 as a Core Regulator of Colonic Inflammation},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70831}
}
EUVIMED